NHS England considered and decided to grant the application. Appeal dismissed.
By application dated 22 March 2021, Mermike UK Ltd (“the Applicant”) applied to NHS Commissioning Board (“NHS England”) for inclusion in the pharmaceutical list at Office F24, 56 Silverbox House, Magnet Road, East Lane Business Park, Wembley, Middlesex, HA9 7FP under Regulation 25.
As a GMS Provider, the contractor has referred the dispute of current market rent assessment as at 1 February 2015 and 1 February 2018 for dispute resolution under the provision of Part 12 of the NHS (General Medical Services Contract) Regulations 2015.
NHS England has referred the matter of rent reimbursement for dispute resolution under the provision of Paragraph 95, Schedule 5 of the NHS (Personal Medical Services Agreement) Regulations 2004 or Paragraph 76 of the NHS (Personal Medical Services Agreement) Regulations 2015.
The Contractor referred the dispute in relation to the Contractor’s general ophthalmic mandatory services contract (the “Contract”) for dispute resolution under the provisions of paragraph 29(1)(b) of Schedule 1 of the General Ophthalmic Services Contracts Regulations 2008 (the “Regulations”).